dr. Mireille Van Gele
No current affiliation with UGent
- ORCID iD
-
0000-0002-7343-4657
Show
Sort by
-
- Journal Article
- A1
- open access
Personalized development of antisense oligonucleotides for exon skipping restores type XVII collagen expression in junctional epidermolysis bullosa
-
Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma
-
Towards the development of a RNAi-based topical treatment for psoriasis : proof-of-concept in a 3D psoriasis skin model
-
Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders
-
In vitro psoriasis models with focus on reconstructed skin models as promising tools in psoriasis research
-
- Journal Article
- A1
- open access
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
-
- Journal Article
- A1
- open access
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma : evaluation of clinical and immunologic response
-
- Journal Article
- A1
- open access
JAK3 as an emerging target for topical treatment of inflammatory skin diseases
-
Exploring the feasibility of whole blood to identify systemic miRNA biomarkers for patients with moderate-to-severe psoriasis
-
- Journal Article
- A2
- open access
Characterization data on the topical carrier DDC642